Objectives: To investigate characteristics of nine carbapenem-non-susceptible (CP-NS) Escherichia coli isolates collected between 1999 and 2005 at a Taiwanese university hospital.
Introduction
The emergence of carbapenem resistance in Enterobacteriaceae has become a matter of great concern. 1 In Escherichia coli, carbapenem resistance remains extremely rare and is mostly attributable to an outer membrane porin deficiency in combination with the production of CMY-2-related AmpC enzymes or CTX-M-type extended-spectrum b-lactamases (ESBLs). 2 -4 The present study was conducted to characterize carbapenem-non-susceptible (CP-NS) E. coli isolates collected between 1999 and 2005 at a university hospital in Taiwan.
Materials and methods

Clinical isolates and patients
A total of 18 345 E. coli isolates were consecutively collected between 1999 and 2005 at the Department of Pathology, National Cheng Kung University Hospital, Tainan, Taiwan. Among these isolates, 17 (0.09%) isolates from 10 patients were non-susceptible (resistant or intermediately susceptible) to imipenem, meropenem or both based on the CLSI (formerly NCCLS) criteria for the standard disc diffusion method. 5 The annual rates of carbapenem nonsusceptibility ranged from 0% to 0. Nine CP-NS isolates from different patients were selected for further examination. Among them, seven isolates were associated with nosocomial infections and five isolates might be acquired at intensive care units. Before isolation, six patients had been exposed to imipenem or meropenem and five patients had been treated with third-or fourth-generation cephalosporins. Five patients died of infections caused by CP-NS isolates. A carbapenem-susceptible isolate (2837-2/05) recovered with a carbapenem-resistant isolate (2837-1/05) from a wound sample was also analysed for comparison. E. coli strain K12 was used as the positive control in analysis of outer membrane proteins (OMPs).
Susceptibility testing
MICs of various antimicrobial agents were determined by the standard agar dilution method and Etest strips (AB Biodisk, Solna, Sweden). 5 Isolates were tested for ESBL production by the CLSI-recommended disc-diffusion confirmatory test and the doubledisc synergy test. The 2-mercaptopropionic acid double-disc potentiation method was used to screen for metallo-b-lactamases (MBLs). 6 
b-Lactamase analyses
Analytical isoelectric focusing was performed on polyacrylamide gels. Hydrolysis of 100 mM imipenem and meropenem by crude preparations of b-lactamases was monitored using a Beckman DU-800 ultraviolet spectrophotometer (Palo Alto, CA, USA) at 297 nm. 4 
PCR experiments
The presence of bla genes related to bla SHV , bla TEM , bla DHA-1 , bla CMY-2 , bla CTX-M-9 , bla CTX-M-13 and bla IMP-2 was detected by PCR and nucleotide sequencing with primers used for PCR. 7 -9 The omp genes were amplified by PCR using primer pairs as follows: h_ECompA-1 (5 0 -CTGGGTAAGGAATAACTG-3 0 ) and h_ECompA-2 (5 0 -ATTTTGGATGATAACGAG-3 0 ) for ompA; com_ompC-1 (HindIII) (5 0 -CCCAAGCTTGCGGGTTGTGGTTTTTGATC-3 0 ) and com_ompC-2 (HindIII) (5 0 -CCCAAGCTTCAACAGTAAAAAGAAG CGGG-3 0 ) for ompC; and OmpF-1 (5 0 -ATCGTCCCTGCTC TGTTAG-3 0 ) and OmpF-2 (5 0 -TAAACGATACCCACAGCAA-3 0 ) for ompF. The sequences of the amplified ompC genes were determined with primers 'com_ompC-1 (HindIII)' and 'seq_ompC' (5 0 -GCAA ATAAAGGCATATAACA-3 0 ). Nucleotide sequences were analysed by use of BLAST (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi).
SDS-PAGE of OMPs
Bacteria were cultured in medium A (7 g of nutrient broth, 1 g of yeast extract, 3.7 g of K 2 HPO 4 , 1.3 g of KH 2 PO 4 and 2 g of glycerol per 1 L) at 378C overnight. OMPs were prepared as described previously 4 and separated by 10% SDS-PAGE with 4 M urea. The gel was stained with 0.1% Coomassie Blue. OMPs suspected of being OmpC, OmpF or OmpA on SDS-PAGE gels from selected isolates were submitted to the National Cheng Kung University Proteomics Research Core Laboratory for nanoelectrospray liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis. The data were analysed by the database search software on the Mascot web site (http://matrixscience.com).
PFGE PFGE analysis of XbaI-digested genomic DNA was carried out with a CHEF Mapper XA apparatus (Bio-Rad Laboratories, Hercules, CA, USA) according to the instruction manual. PFGE patterns were interpreted in accordance with the criteria of Tenover et al.
10
Cloning experiment
The
Northern blot assays
Bacteria were cultured in 40 mL of medium A for 7 h to late log phase. RNA samples were prepared and northern blotting was performed as described previously. 11 The probes used for hybridization were prepared by PCR with primers OmpA-1 (5 0 -GGAATT CCCGTCTGGAATACCAGTG-3 0 ) and OmpA-2 (5 0 -CCAAGCTTG TTGCCAGTAACCGGGTT-3 0 ) for ompA; OmpC_conserve-1 (5 0 -TCCAGCTCCAAACGTACC-3 0 ) and OmpC_conserve-2 (5 0 -GG TACTGAGCAACAGCTT-3 0 ) for ompC; and OmpF-1 and OmpF-2 for ompF.
Results and discussion
By the phenotypic detection methods for ESBLs and MBLs, isoelectric focusing and PCR experiments, eight of the nine CP-NS isolates were found to produce the CMY-2 AmpC enzyme ( pI ¼ 9.0), and the CTX-M-14-type ESBL ( pI ¼ 8.1) was detected in one CMY-2 producer ( Table 1 ). The remaining one isolate was found to co-produce the SHV-12 ESBL ( pI ¼ 8.2) and the IMP-8 MBL ( pI ¼ 8.2). Moreover, the TEM-1 narrow-spectrum b-lactamase ( pI ¼ 5.4) was detected in eight isolates. Isolates 2837-2/05 and 2837-1/05 had the same b-lactamases. Among the nine isolates, only the IMP-8 producer showed marked carbapenemase activity against imipenem in the hydrolysis analysis (data not shown).
The results of susceptibility testing are shown in Table 1 . Among the nine CP-NS isolates, high-level resistance to imipenem and ertapenem (MIC, 128 mg/L) was detected in four and five isolates, respectively. All nine isolates showed high-level resistance (MIC, 128 mg/L) to cefotaxime, ceftazidime and aztreonam. Seven isolates were resistant to cefepime (MIC, 32 mg/L). Isolates 2837-2/05 and 2837-1/05 revealed discernible differences only in susceptibilities to carbapenems and cefepime.
PFGE revealed eight distinct patterns among eight of the nine CP-NS E. coli isolates (Table 1) . One isolate could not be typed probably due to lysis of its genomic DNA. Isolates 2837-1/05 and 2837-2/05 differed only by three bands, suggesting that they were from the same clone.
The results of SDS-PAGE are shown in Figure 1 . The expressions of OmpC and OmpF were decreased in all CP-NS isolates. For isolate 2837-2/05, only OmpA and OmpC were obtained.
The presence of the three omp genes was detected by PCR in all study isolates (data not shown). Sequence (Table 1 ).
In the northern blot assay, transcripts of ompC were markedly lower in six of the nine CP-NS isolates and slightly decreased in the remaining three CP-NS isolates when compared with E. coli K12 and isolate 2937-02/05. Moreover, all CP-NS isolates except 784/99 showed decreased transcription of ompF. Transcription of ompA appeared to increase slightly in all CP-NS isolates (data not shown).
The ompC gene from 2837-02/05 was cloned and used to transform isolate 2837-1/05. The transformant revealed increased transcription and expression of ompC (Figure 1 ) and became susceptible to carbapenems (Table 1) , indicating the importance of OmpC in carbapenem susceptibility. The transformation by ompF had no significant effects in the susceptibility to any carbapenems ( Table 1 ), suggesting that the loss of OmpF has little role in carbapenem resistance in our CP-NS E. coli isolates.
The present study revealed that carbapenem resistance in E. coli in this Taiwanese hospital was mainly attributed to the combination of the loss of OmpC and the presence of CMY-2. MICs of imipenem and meropenem varied remarkably among the CP-NS isolates, suggesting the presence of other resistance mechanisms. The IMP-8 MBL was identified in one CP-NS isolate. Although IMP-8 has hydrolytic activity against carbapenems, the acquisition of a bla IMP-8 plasmid did not confer substantive resistance to carbapenems in E. coli. 8, 12 Thus, the loss of OmpC may also play an important role in carbapenem resistance in the IMP-8 producer.
All patients with the CP-NS E. coli isolates had been exposed to carbapenems and/or extended-spectrum cephalosporins before isolation. Genetic diversity was demonstrated by PFGE among the CP-NS E. coli isolates. These findings suggest that the emergence of carbapenem resistance in E. coli in this hospital might be caused by stepwise accumulation of multiple drug-resistance determinants in different clones under the selective pressure created by the use of extended-spectrum cephalosporins or carbapenems. The majority of the CP-NS isolates were resistant to nearly all of the antimicrobials tested, and a high mortality rate was observed among our patients infected by the CP-NS isolates. The spread of such multidrug-resistant strains may become a serious problem in Taiwan.
